OneAscent Wealth Management’s Idexx Laboratories IDXX Stock Holding History

OneAscent Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-382	Closed	-$206K	–	129
2024 Q1	$206K	Buy	+382	New	+$209K	0.08%	166
2023 Q3	–	Sell	-432	Closed	-$217K	–	170
2023 Q2	$217K	Buy	432 +4	+0.9%	+$1.92K	0.1%	91
2023 Q1	$214K	Buy	+428	New	+$205K	0.08%	167
2022 Q4	–	Sell	-709	Closed	-$231K	–	169
2022 Q3	$231K	Buy	709 +2	+0.3%	+$735	0.12%	125
2022 Q2	$248K	Buy	707 +78	+12%	+$31.8K	0.13%	141
2022 Q1	$344K	Buy	+629	New	+$331K	0.17%	127
2021 Q4	–	Sell	-508	Closed	-$316K	–	99
2021 Q3	$316K	Buy	+508	New	+$341K	0.36%	65
2021 Q1	$415K	Buy	848 +74	+10%	+$37.1K	0.18%	140
2020 Q4	$387K	Buy	+774	New	+$346K	0.18%	135

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OneAscent Wealth Management's IDXX Position: Q2 2024 in Review

OneAscent Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 382 shares — an estimated $206K sold.

OneAscent Wealth Management first reported a position in IDXX in Q4 2020 and held it in 9 quarters. The position peaked at $415K in Q1 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

OneAscent Wealth Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
OneAscent Wealth Management sold 382 Idexx Laboratories shares in Q2 2024, an estimated $206K.
OneAscent Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 9 quarters.
OneAscent Wealth Management's Idexx Laboratories position peaked at $415K in Q1 2021.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on OneAscent Wealth Management's 13F filing for Q2 2024, filed 17 Jul 2024.